How Much Bacteriostatic Water for Tesamorelin? (Chart)

Standard Reconstitution Ratios for Tesamorelin Vials

Determining how much bacteriostatic water for tesamorelin depends primarily on the lyophilized cake mass inside the vial and the target concentration required for your analytical workflow. In preclinical laboratory settings, adding 1.0 mL to 2.0 mL of 0.9% benzyl alcohol-preserved bacteriostatic water to a standard vial of Tesamorelin 10mg yields standard concentrations between 5.0 mg/mL and 10.0 mg/mL.

Tesamorelin is a synthetic 44-amino acid growth hormone-releasing hormone (GHRH) analog featuring a trans-3-hexenoic acid group attached to the N-terminal tyrosine residue. This modification enhances stability against enzymatic cleavage by dipeptidyl peptidase-IV (DPP-IV). Preclinical models demonstrate that maintaining consistent peptide concentration during reconstitution is critical for reproducible receptor binding assays and somatotroph activation studies.

When preparing stock solutions across the broader catalog of all peptides, research teams must account for total solvent displacement. While the physical volume of the lyophilized powder mass slightly displaces fluid, calculated additions of 1.0 mL, 2.0 mL, 3.0 mL, or 5.0 mL of bacteriostatic water provide predictable working stock concentrations suited for automated micro-pipetting.

Master Tesamorelin Reconstitution Reference Chart

The following master reference chart delineates the resulting stock concentrations when reconstituting various lyophilized Tesamorelin vial masses (2 mg, 5 mg, and 10 mg) with common diluent volumes (1 mL, 2 mL, 3 mL, and 5 mL) of bacteriostatic water.

• 2 mg Vial + 1.0 mL Diluent = 2.0 mg/mL (2.0 µg/µL) • 2 mg Vial + 2.0 mL Diluent = 1.0 mg/mL (1.0 µg/µL) • 2 mg Vial + 3.0 mL Diluent = 0.67 mg/mL (0.67 µg/µL) • 2 mg Vial + 5.0 mL Diluent = 0.40 mg/mL (0.40 µg/µL)

• 5 mg Vial + 1.0 mL Diluent = 5.0 mg/mL (5.0 µg/µL) • 5 mg Vial + 2.0 mL Diluent = 2.5 mg/mL (2.5 µg/µL) • 5 mg Vial + 3.0 mL Diluent = 1.67 mg/mL (1.67 µg/µL) • 5 mg Vial + 5.0 mL Diluent = 1.0 mg/mL (1.0 µg/µL)

• 10 mg Vial + 1.0 mL Diluent = 10.0 mg/mL (10.0 µg/µL) • 10 mg Vial + 2.0 mL Diluent = 5.0 mg/mL (5.0 µg/µL) • 10 mg Vial + 3.0 mL Diluent = 3.33 mg/mL (3.33 µg/µL) • 10 mg Vial + 5.0 mL Diluent = 2.0 mg/mL (2.0 µg/µL)

Selecting the proper volume depends on the resolution of your pipetting equipment. For micro-titration assays, higher concentrations (such as 10 mg reconstituted in 1.0 mL or 2.0 mL) reduce total liquid addition to cell cultures or assays. For general bench assays, lower concentrations prevent measurement errors caused by high viscosity or microscopic hold-up volumes inside pipette tips.

The Mathematical Formula Behind Reconstitution Calculations

To calculate exact concentrations for custom research volumes, investigators utilize the fundamental mass-concentration equation: Concentration (C) = Mass (m) / Volume (V) Where 'm' is the total mass of pure active peptide contained in the vial expressed in milligrams (mg), and 'V' is the volume of sterile bacteriostatic water added in milliliters (mL).

For instance, if a laboratory researcher reconstitutes a 10 mg vial of high-purity GHRH analog with 2.0 mL of diluent, the working concentration calculation is: C = 10 mg / 2.0 mL = 5.0 mg/mL

To convert this value into microgram per microliter (µg/µL) units frequently used for microplate assay preparation, observe that 1 mg/mL is equivalent to 1 µg/µL. Thus, a 5.0 mg/mL stock solution equals 5.0 µg/µL. If a protocol requires a target dosage of 250 µg in a preclinical animal model, the required pipette volume (V_p) is derived via: V_p = Target Mass / Stock Concentration = 250 µg / 5.0 µg/µL = 50 µL.

Researchers can streamline multi-variable laboratory conversions without manual arithmetic by using our interactive reconstitution calculator tool.

Step-by-Step Laboratory Reconstitution Protocol

Executing reconstitution under strict aseptic conditions prevents bacterial contamination and preserves peptide integrity. Begin by bringing both the lyophilized vial and the bacteriostatic water to ambient room temperature (20°C to 25°C) inside a certified Class II laminar flow hood.

Sanitize the rubber septum of the peptide vial using a freshly prepared 70% isopropyl alcohol wipe and allow it to air-dry completely. Using a sterile polypropylene syringe fitted with a 21-gauge to 25-gauge needle, draw up the exact predetermined volume of bacteriostatic water.

Insert the needle through the center of the rubber stopper at a slight 45-degree angle. Direct the flow of diluent slowly down the glass inner wall of the vial. Never force liquid directly onto the lyophilized cake, as high hydrostatic pressure can rupture delicate peptide tertiary structures and induce shear-stress aggregation.

Allow the liquid to gradually saturate the cake. Gently swirl the vial in a circular motion on the benchtop. Do not shake, vortex, or invert vigorously, as foam formation indicates protein denaturation at the air-water interface. Reconstitution is complete once the solution becomes clear, colorless, and free of visible particulates.

Comparative Analysis: GHRH Analogs and Secretagogues

Tesamorelin belongs to a distinct class of growth hormone secretagogues studied extensively for its binding affinity to GHRH receptors on pituitary somatotrophs. In preclinical literature, researchers frequently compare Tesamorelin against other secretagogues such as CJC-1295, Ipamorelin, and Sermorelin to evaluate differences in half-life, receptor selectivity, and downstream IGF-1 induction.

While Sermorelin represents the minimal 29-amino acid functional fragment of endogenous GHRH (GHRH 1-29), Tesamorelin features an N-terminal modification that confers significantly greater resistance to enzymatic degradation. Preclinical studies suggest that this structural modification alters signaling kinetics compared to CJC-1295 (which utilizes a Drug Affinity Complex to bind serum albumin) or Ipamorelin (a selective ghrelin/GHS-R agonist that acts independently of GHRH receptors).

Because of variations in hydrophobic amino acid sequences and molecular weights among these compounds, each peptide exhibits distinct solubility profiles. Tesamorelin reconstitutes rapidly in neutral-to-slightly-acidic bacteriostatic water, whereas highly hydrophobic analogs may require longer wetting times or precise pH buffering.

Aliquoting Protocols and Cryogenic Storage Guidance

Repeated freeze-thaw cycles subject peptide chains to cryo-concentration effects and mechanical shear, accelerating hydrolysis and peptide aggregation. To maintain maximal bioactivity over multi-week experimental series, implementing an aliquoting protocol immediately following initial reconstitution is mandatory.

Divide the reconstituted solution into single-use micro-aliquots using sterile, low-protein-binding polypropylene microcentrifuge tubes (e.g., Eppendorf LoBind). Volume size per tube should match the exact aliquot required for a single experimental run or day of testing (e.g., 50 µL to 200 µL).

Label each aliquot with the peptide name, batch number, concentration, and reconstitution date. Store single-use aliquots intended for immediate use within 28 days at 2°C to 8°C. For long-term preservation up to 12 months, freeze aliquots immediately at -20°C or -80°C. Avoid frost-free laboratory freezers, as their automatic temperature fluctuation cycles induce rapid peptide degradation.

Buffer Compatibility, Solvent Properties, and Benzyl Alcohol Mechanics

Standard reconstituted solutions rely on bacteriostatic water containing 0.9% (9 mg/mL) benzyl alcohol. Benzyl alcohol acts as a bacteriostatic preservative by disrupting bacterial cell membrane permeability without destabilizing the secondary or tertiary structure of short-to-medium chain peptides.

For short-term in vitro assays where benzyl alcohol might interfere with cell viability, sterile 0.9% normal saline or phosphate-buffered saline (PBS, pH 7.4) may be substituted as the diluent. However, unpreserved saline or PBS solutions lack antimicrobial agents and must be used immediately or discarded within 24 hours.

Avoid using hypertonic or high-pH buffers for initial dissolution. Preclinical data indicate that reconstituted GHRH analogs remain stable between pH 5.0 and 6.5. Deviating into alkaline pH ranges accelerates deamidation at asparagine and glutamine residues, reducing molecular purity over time.

Quality Verification: Analytical Standards and COA Metrics at PX1 Research

Accurate reconstitution math relies on starting with verified mass and purity. Substandard or underfilled vials lead to erroneous concentration calculations that compromise analytical precision. Every batch of research peptides supplied by PX1 Research undergoes rigorous testing in ISO 17025 accredited analytical laboratories.

Purity is validated via High-Performance Liquid Chromatography (HPLC) coupled with Mass Spectrometry (MS) to confirm exact molecular mass (44 amino acids, theoretical average MW ~5135.9 Da) and ensure >99% chromatographic purity. Furthermore, every lot is subjected to Chromogenic Reagent Endotoxin Testing to ensure levels remain strictly below <0.01 EU/mg, well within standard research limits.

Researchers can inspect lot-specific documentation, mass spectra, and analytical purity profiles directly through our public certificate of analysis portal prior to initiating experimental protocols. All PX1 compounds are USA-manufactured in GMP-compliant facilities and shipped directly from our primary distribution hubs in California and Arizona.

Digital Volumetric Automation and Research Workflow Integration

Modern high-throughput screening and automated liquid handling systems require digital integration of volumetric parameters. When programming automated liquid handlers (e.g., Tecan or Hamilton platforms), density corrections for 0.9% benzyl alcohol solutions must be configured into liquid class definitions.

The density of bacteriostatic water at 20°C is approximately 1.002 g/mL, which is practically equivalent to pure water for standard volumetric work. However, when pipetting small volumes (<10 µL) from stock concentrations above 5 mg/mL, tip surface tension and liquid retention can introduce systematic errors.

Investigators are encouraged to reference our extended research library for protocol optimization guidance, or consult our wholesale program for bulk laboratory supply accounts requiring custom lot sizes or standardized batch volumes.